Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03229993 Completed - Clinical trials for Percutaneous Coronary Intervention (PCI)

OCT in Borderline Coronary Artery Lesions

Start date: December 31, 2017
Phase: N/A
Study type: Interventional

To find out the safety and efficacy of Optical Coherence Tomography (OCT) in the evaluation and treatment of angiographically borderline coronary artery lesions in a Chinese population, and to compare the effectiveness of OCT versus SPECT in treating such subjects. All the participants included in the study will be those that are found to have borderline coronary artery lesions on coronary angiography, in whom the investigators feel that OCT will be useful to assess whether PCI will be of benefit to the treatment of the lesion pathology, or whether optimal medical therapy is the most appropriate treatment modality. Those participants who declined OCT will be offered SPECT as an alternative method to assess and treat the borderline coronary artery stenosis. It is estimated that OCT guided "PCI or not" has a non-inferiority to SPECT's in the borderline coronary artery stenosis.

NCT ID: NCT03229707 Completed - Clinical trials for Accuracy of Dental Shade Selection in the Aesthetic Zone

Impact Of Digital Photography & Conventional Method On The Accuracy Of Dental Shade Matching In The Esthetic Zone

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

The aim of this study: Is to evaluate the accuracy of digital photography in optimizing shade matching when compared to conventional method of shade selection.

NCT ID: NCT03229668 Completed - Clinical trials for Pregabalin on Catheter Related Bladder Discomfort

Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Urological Surgical Operations

Start date: July 28, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of this study is to assess the effect of pregabalin administration on catheter-related bladder discomfort (CRBD). The study group includes patients that are about to be subjected to urological operations because of the high incidence of CRBD observed in this kind of surgical population.

NCT ID: NCT03229538 Completed - Clinical trials for Inflammatory Response

STeroids to REduce Systemic Inflammation After Infant Heart Surgery

STRESS
Start date: October 18, 2017
Phase: Phase 3
Study type: Interventional

This study's objective is to determine the pharmacokinetics (PK)/pharmacodynamics (PD), safety and efficacy of methylprednisolone in infants undergoing heart surgery with cardiopulmonary bypass. This is a prospective, double blind, multi-center, placebo-controlled safety and efficacy study. Blood samples will be collected from a subset of enrolled study participants to evaluate multiple dose methylprednisolone PK/PD. Participants will be randomized in a 1:1 fashion to intravenous methylprednisolone versus placebo. Study drug/placebo will be administered 8 to 12 hours before the anticipated start time of surgery and in the operating room at the time of initiation of cardiopulmonary bypass. Patients will be followed for primary and secondary outcomes for the duration of their hospitalization. Serious study drug-related adverse events will be collected for 7 days after the last dose of study drug.

NCT ID: NCT03229278 Completed - Lymphoma Clinical Trials

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Start date: October 3, 2017
Phase: Phase 1
Study type: Interventional

This phase I trial studies the best dose and side effects of trigriluzole in combination with nivolumab and pembrolizumab in treating patients with solid malignancies or lymphoma that has spread to other places in the body or cannot be removed by surgery. Trigriluzole may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as nivolumab and pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Giving trigriluzole in combination with nivolumab and pembrolizumab may work better at treating patients with solid malignancies or lymphoma.

NCT ID: NCT03229174 Completed - Parkinson Disease Clinical Trials

Brain Perfusion & Oxygenation in Parkinson's Disease With NOH

Start date: August 23, 2018
Phase: Phase 4
Study type: Interventional

This is a double blind placebo controlled trial in Parkinson's disease (PD) patients with neurogenic orthostatic hypotension (NOH). Investigators hypothesize that the study drug (droxidopa) may improve cerebral perfusion more robustly than systemic BP, possibly by direct action within the CNS vasculature. This study is designed to determine if droxidopa improves cerebral perfusion measures in PD patients with NOH, in addition to peripheral BP measures and subjective responses.

NCT ID: NCT03229161 Completed - Clinical trials for Gestational Diabetes Mellitus in Pregnancy

Interval Walking Intervention for Pregnant Women Diagnosed With Gestational Diabetes Mellitus

Start date: January 3, 2017
Phase: N/A
Study type: Interventional

It is well-known that regular physical activity (PA) can improve glycemic control and physical fitness in type 2 diabetes patients. However, studies examining the effects of PA in patients with gestational diabetes mellitus (GDM) are limited. Interval walking training (IWT) is a careful type of PA consisting of repeatedly cycles of 3 min. fast and slow walking. The investigators aimed to examine, if IWT is feasible as PA intervention for GDM patients, and to examine the effects of IWT on glycemic control, PA levels and physical fitness.

NCT ID: NCT03229135 Completed - Clinical trials for Pneumonia Gram-Positive Bacterial

Loading Regimen,Serum Trough Concentrations,Efficacy and Safety in Pneumonia Patients With Gram-positive Infections

Start date: February 1, 2015
Phase: N/A
Study type: Observational

This was a retrospective study that all teicoplanin-treated adult patients with Gram-positive infections admitted to Zhengzhou Central Hospital affiliated to Zhengzhou University from February 2015 to August 2016.

NCT ID: NCT03228784 Completed - Clinical trials for Incidence and Severity of Dry Eye After Myopic LASIK

The Effect of Ablation Depth on Dry Eye After LASIK Treatment of Myopia

Start date: June 1, 2013
Phase: N/A
Study type: Interventional

The study tried to find the relation between ablation depth and degree of dryness after LASIK treatment of myopic patients

NCT ID: NCT03228589 Completed - Clinical trials for Side Effects of Acetylsalicylic Acid Use

The Effect of a Probiotic Strain on Aspirin-induced GI Damage.

PIP-D
Start date: July 15, 2017
Phase: Phase 2
Study type: Interventional

This trial is a single-site, randomised, double-blind, placebo-controlled, two-armed, parallel-group trial in healthy, adult volunteers. The trial will investigate the effect of daily intake of a probiotic strain versus placebo when co-administered to daily intake of 300mg of Aspirin. The objective is to investigate the ability of the probiotic strain to attenuate and/or reverse Aspirin-induced deterioration of the small intestine.